Q1A(R2): Stability testing of new drug substances and products
And since its not yet approved for use in children, any prescription for obesity, type 2 diabetes, or both is technically off-label
Lab analysis of our native whey protein verifies that our whey contains less than 1% non-denatured casein
Li YF, Wang W, Mayhan WG, Patel KP
Spending is anticipated to increase as manufacturers invest in outcome trials and larger production networks
In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group